Pharmacokinetics and pharmacodynamics of ticagrelor when treating non-ST elevation acute coronary syndromes.

about

Pharmacokinetics and pharmacodynamics of ticagrelor when treating non-ST elevation acute coronary syndromes.

Item

http://www.wikidata.org/entity/Q41060485

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Pharmacokinetics and pharmacod ...... tion acute coronary syndromes.

@en

type

Item

label

Pharmacokinetics and pharmacod ...... tion acute coronary syndromes.

@en

prefLabel

Pharmacokinetics and pharmacod ...... tion acute coronary syndromes.

@en

P1476

Pharmacokinetics and pharmacod ...... ation acute coronary syndromes

@en

P2093

Francesco Monitillo

http://www.w3.org/2001/XMLSchema#string

Mario Chiatto

http://www.w3.org/2001/XMLSchema#string

Pasquale Caldarola

http://www.w3.org/2001/XMLSchema#string

Roberto Valle

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

Aspirin dose for the prevention of cardiovascular disease: a systematic review

2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Platelet reactivity during ticagrelor maintenance therapy: a patient-level data meta-analysis.

The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electroca

Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model.

P304

977-993

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425255.2015.1037279

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Massimo Iacoviello

Nadia Aspromonte

P577

2015-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25882759

http://www.w3.org/2001/XMLSchema#string